Received Mar 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | B4LM4 | — |
broke out in hives on abdomen chest and back; This non-serious case was reported by a nurse via call center representative and described the occurrence of hives in a 60-year-old male patient who received Herpes zoster (Shingrix) (batch number B4LM4, expiry date 26-AUG-2027) for prophylaxis. On 04-MAR-2026, the patient received the 1st dose of Shingrix. On 09-MAR-2026, 5 days after receiving Shingrix, the patient experienced hives (Verbatim: broke out in hives on abdomen chest and back). The patient was treated with hydrocortisone. The outcome of the hives was resolved. It was unknown if the reporter considered the hives to be related to Shingrix. It was unknown if the company considered the hives to be related to Shingrix. Additional Information: GSK Receipt Date: 10-MAR-2026 The patient was administered a dose of the vial and vial Shingrix. The patient broke out in hives on the abdomen, chest, and back. The patient left a message in the morning stating that he put Hydrocortisone cream on it and it was almost completely gone.